Research report explores the Laxatives Market Forecast to 2022 - By Credence Research

The latest market report published by Credence Research, Inc. “Global Laxatives Market Size - Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016-2022,” the laxatives market was valued at USD 4,739.42 Mn in 2015, and is expected to reach USD 6,948.07 Mn by 2022, expanding at a CAGR of 5.6% from 2016 to 2022.

Market Insights
Constipation is among the most common gastrointestinal malfunctions observed across all age groups. The prevalence of constipation in the general population is between 0.7% to 79% (with a median at 16%) (Epidemiology of constipation in children and adults: a systematic review, 2010), across all age groups. Constipation prevalence is high among the geriatric population and higher in females. The median province of constipation among children is 12%. With the growing burden of the condition there is a constant struggle among care givers and drug manufacturers to come up with more evolved treatment options.

Browse the full report Global Laxatives Market - Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016–2022 at http://www.credenceresearch.com/report/laxatives-market

The burden of constipation management in terms of time and cost is further higher in geriatric patients under palliative care. This patient group is more inclined towards prescription drug administration for treating constipation and thus forms a large consumer base for laxatives. Polyethylene Glycol is observed to be the largest segment in the global laxatives market and is expected to reach worth USD 1,271.98 by 2022. Moreover, it is also the fastest growing segment in the laxatives market.

Polyethylene glycol is an osmotic laxative and is used for short-term treatment of constipation and is used intermittently in cases of chronic constipation. Polyethylene glycol laxatives are also used intestinal purges for use colonoscopy preparation. Versatility of polyethylene glycol laxatives is observed to be a significant contributor to its rising demand in the laxatives market. Moreover, polyethylene glycol is also among the highest selling laxatives in the developed markets. MiraLAX by Schering-Plough (through licensing agreement with Braintree Laboratories) is the biggest brand name for polyethylene glycol laxatives and is claimed to be the most successful Rx to OTC switch in the laxatives category.

Media Contact:
Mr. Chris Smith
Phone: +1-800-361-8290
Email: sales@credenceresearch.com
Website: http://www.credenceresearch.com/

Comments

Post a Comment

Popular posts from this blog

Hospital Infection Prevention And Control Market - Global Market Size, Share, Trend, Market Growth, Analysis And Industry Forecasts to 2025

Image
​ The latest market report published by Credence Research, Inc. “ Hospital Infection Prevention and Control Market  - Growth, Future Prospects, and Competitive Analysis, 2016 - 2024,” the global hospital infection prevention and control market was valued at US$ 142.6 Mn in 2015, and is expected to reach US$ 245.6 Mn by 2024, expanding at a CAGR of 6.3% from 2016 to 2024. Market Insights The market experts suggest that healthcare associated infections are a costly issue faced by many hospitals across the globe. Hospital acquired infections are type of infections that are observed in patients during the course of receiving treatment for unrelated conditions. According to the World Health Organization (WHO), infectious waste contributes in this way to the risk of nosocomial infections, putting the health of hospital personnel, and patients, at risk. The Centers for Disease Control and Prevention (CDC) statistically suggested that, with approximately 300,000 occurrences each year,
Read more

Global Non-Invasive Prenatal Testing Market Research,Trends And Statistics Report 2017 - 2025

According to the latest report published by Credence Research, Inc. “Non-Invasive Prenatal Testing Market Growth, Future Prospects and Competitive Analysis, 2016-2022,” the  non-invasive prenatal testing market size  was valued at USD 613.0 Mn in 2015, and is expected to reach USD 1,939.9 Mn by 2022, expanding at a CAGR of 17.9% from 2016 to 2022. Market Insights                                             The global non-invasive prenatal tests (NIPT) market is experiencing a double-digit growth facilitated by market drivers such as rise in average maternity age, growing incidence of chromosomal abnormalities that demand early and non-invasive detection. Other major factor that aids to the growth of this market is rise in healthcare expenditure. Browse the full report Non-Invasive Prenatal Testing: Market Growth, Future Prospects and Competitive Analysis, 2016-2022 at  http://www.credenceresearch.com/report/non-invasive-prenatal-testing-market  Non-invasive prenatal tes
Read more

Treatment Resistant Depression Market - Global Market Size, Share, Trend, Market Growth, Analysis And Industry Forecasts to 2025

​ According to the latest report published by Credence Research, Inc. “Treatment Resistant Depression Market: Growth, Future Prospects and Competitive Analysis, 2016-2024,” the  treatment resistant depression market size  was valued at US$ 863.9 Mn in 2015, and is expected to reach US$ 1,129.1 Mn by 2024, expanding at a CAGR of 3% from 2016 to 2024. Market Insights Depression is among the most common mental disorders worldwide, affecting approximately 6.7% individuals in the U.S. alone, each year (Anxiety and Depression Association of America). This condition also creates a significant economic burden on the healthcare system. Patients diagnosed with treatment resistant depression has failed two or more antidepressant therapies. Such patients present a critical therapeutic challenge to mental health as this patient group requires specialized TRD management. Browse the full report Treatment Resistant Depression Market: Growth, Future Prospects and Competitive Analysis, 2016-2024
Read more